Lilly inks $3.2B Morphic buyout to take on Takeda in IBD Fierce BiotechEli Lilly to Buy Morphic Holding for $3.2 Billion The Wall Street JournalLilly Agrees to Buy US Biotech Morphic in $3.2 Billion Deal Yahoo FinanceLilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease | Eli Lilly and Company Investors | Eli Lilly and CompanyMorphic Stock Surges 78%. It’s Being Bought by Eli Lilly. Barron’s